Osmolex ER
Osmolex ER(Amantadine) side effects drug center
Osmolex ER Side Effects Center
Osmolex ER (amantadine extended-release tablets) is indicated for the treatment of drug-induced extrapyramidal reactions in adult patients with Parkinson's disease.
The initial dosage of Osmolex ER is 129 mg orally once daily in the morning. The dosage may be increased in weekly intervals to a maximum daily dose of 322 mg once daily in the morning. Osmolex ER may interact with anticholinergic drugs, drugs affecting urinary pH (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), live influenza vaccines, and alcohol. Tell your doctor all medications and supplements you use. Osmolex ER is not recommended for use during pregnancy; it may harm a fetus. Osmolex ER passes into breast milk but its effects on nursing infants is unknown. Consult your doctor before breastfeeding.
Osmolex ER Consumer Information
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
- extreme drowsiness, falling asleep suddenly even after feeling alert;
- a light-headed feeling, like you might pass out;
- shortness of breath (even with mild exertion), swelling in your hands or feet;
- painful or difficult urination;
- depression, agitation, aggression, behavior changes, hallucinations, thoughts of hurting yourself;
- a seizure; or
- severe nervous system reaction--very stiff (rigid) muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors.
You may have increased sexual urges, unusual urges to gamble, or other intense urges while taking this medicine. Talk with your doctor if this occurs.
Side effects may be more likely in older adults.
Common side effects may include:
- dizziness, falls;
- dry mouth;
- swelling in your legs or feet;
- nausea, constipation; or
- sleep problems (insomnia).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Osmolex ER (Amantadine)
Osmolex ER Professional Information
SIDE EFFECTS
The following serious adverse reactions are described elsewhere in the labeling:
- Falling Asleep During Activities of Daily Living and Somnolence [see WARNINGS AND PRECAUTIONS]
- Suicidality and Depression [see WARNINGS AND PRECAUTIONS]
- Hallucinations/Psychotic Behavior [see WARNINGS AND PRECAUTIONS]
- Dizziness and Orthostatic Hypotension [see WARNINGS AND PRECAUTIONS]
- Withdrawal-Emergent Hyperpyrexia and Confusion [see WARNINGS AND PRECAUTIONS]
- Impulse Control/Compulsive Behaviors [see WARNINGS AND PRECAUTIONS]
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Immediate-Release Amantadine
The adverse reactions listed in Table 2 were identified in clinical studies of immediate-release amantadine. The most common adverse reactions reported in ≥5% of patients at the recommended dosage of immediate-release amantadine were nausea, dizziness/lightheadedness, and insomnia.
Table 2: Incidence of Adverse Reactions from Pooled
Studies of Immediate-Release Amantadine
5 to 10% | 1 to 5% | 0.1 to 1% | Less than 0.1% |
Nausea | Depression | Congestive heart failure | Convulsion |
Dizziness/ lightheadedness | Anxiety and irritability | Psychosis | Leukopenia |
Insomnia | Hallucinations | Urinary retention | Neutropenia |
Confusion | Dyspnea | Eczematoid dermatitis | |
Anorexia | Skin rash | Oculogyric episodes | |
Dry mouth | Vomiting | Suicidal attempt | |
Constipation | Weakness | Suicide | |
Ataxia | Slurred speech | Suicidal ideation | |
Livedo reticularis | Euphoria | ||
Peripheral edema | Thinking abnormality | ||
Orthostatic hypotension | Amnesia | ||
Headache | Hyperkinesia | ||
Somnolence | Hypertension | ||
Nervousness | Decreased libido | ||
Dream abnormality | Visual disturbance | ||
Agitation | Punctate subepithelial or other corneal opacity | ||
Dry nose | Corneal edema | ||
Diarrhea | Decreased visual acuity | ||
Fatigue | Sensitivity to light | ||
Optic nerve palsy |
Read the entire FDA prescribing information for Osmolex ER (Amantadine)
&Copy; Osmolex ER Patient Information is supplied by Cerner Multum, Inc. and Osmolex ER Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.